Lv1
70 积分 2024-07-07 加入
Kidney immunology from pathophysiology to clinical translation
16天前
已完结
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy
18天前
已关闭
OP0207 EFFICACY AND SAFETY OF EMAPALUMAB IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME IN STILL'S DISEASE: RESULTS FROM A POOLED ANALYSIS OF TWO PROSPECTIVE TRIALS
23天前
已关闭
Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome
1个月前
已完结
Development of a Long-Acting Interleukin-11 Antagonist for the Treatment of Renal Fibrosis
1个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1个月前
已完结
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
1个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
1个月前
已完结
CD137 (4-1BB) and T-Lymphocyte Exhaustion
1个月前
已完结
Immune and inflammatory mechanisms and therapeutic targets of gout: An update
2个月前
已完结
皖公网安备34019202002308
